implementation_international_drug_vocabulary
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revision Both sides next revision | ||
|
implementation_international_drug_vocabulary [2019/07/22 16:24] ekorchmar |
implementation_international_drug_vocabulary [2019/07/22 16:27] ekorchmar |
||
|---|---|---|---|
| Line 3: | Line 3: | ||
| ==== Combined target structure ==== | ==== Combined target structure ==== | ||
| - | To incorporate a new set of drug information, a structure should be achieved that contains every Concept only once and preserves the RxNorm structure, no matter which vocabulary the additional Concept is coming from. In a way, it should create a mixed RxNorm/drug vocabularies union. | + | Standard concepts in [[documentation:vocabulary:drug|Drug domain]] are placed in a single comprehensive hierarchy based on their attributes. To correctly implement a vocabulary in CDM and find or build an counterpart for each source drug concept, following attributes must be extracted: |
| - | + | ||
| - | + | ||
| - | + | ||
| - | Standard concepts in [[documentation:vocabulary:drug|Drug domain]] are placed in a single comprehensive hierarchy based on their attributes. To correctly implement a vocabulary in CDM, following attributes must be extracted: | + | |
| - **Ingredients**: active substance(-s) in pharmacological preparation. Examples: Aspirin, Trastuzumab, Ibuprofen etc.; | - **Ingredients**: active substance(-s) in pharmacological preparation. Examples: Aspirin, Trastuzumab, Ibuprofen etc.; | ||
| Line 59: | Line 55: | ||
| Brand Names that are simple combinations of generic international name of active substance and manufacturer name (e.g. "Aspirin Bayer") should not appear as attributes for Drug Products. Manufacturer information should be stored as a concept with Supplier class. | Brand Names that are simple combinations of generic international name of active substance and manufacturer name (e.g. "Aspirin Bayer") should not appear as attributes for Drug Products. Manufacturer information should be stored as a concept with Supplier class. | ||
| - | Concepts that belong to the source vocabulary, but do not belong to Drug domain by OMOP rules., should be classified as 'Device'. Typically, these belong to different substance groups: | + | Concepts that belong to the source vocabulary, but do not belong to Drug domain by OMOP CDM conventions, should be classified as 'Device'. Typically, these belong to different substance groups: |
| * Radiographic contrasts and dyes (barium sulfate, radiolabeled iodides) | * Radiographic contrasts and dyes (barium sulfate, radiolabeled iodides) | ||
| * Nutritional supplements without stated mechanism of pharmaceutical action (e.g. herbal complexes, homeopathic preparations) | * Nutritional supplements without stated mechanism of pharmaceutical action (e.g. herbal complexes, homeopathic preparations) | ||
implementation_international_drug_vocabulary.txt · Last modified: 2021/06/09 10:15 by adavydov
Page Tools
